Adler Juvebene, Tabletten

7680687450010 CH-68745 Tabletten
Adler Juvebene, Tabletten
Adler Juvebene, Tabletten
Adler Juvebene, Tabletten
1 / 3
google

Article details

Package size
400
Selling units
400
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/06/2023
Patient information leaflet
Français
06/06/2023
Patient information leaflet
Italien
06/06/2023

Detailed composition

Substance Quantity Type Category
No.2 calcium phosphoricum (HAB)
50.0 MG Substance Wirkstoff (Principe actif)
No.4 kalium chloratum (HAB)
50.0 MG Substance Wirkstoff (Principe actif)
No.5 kalium phosphoricum (HAB)
50.0 MG Substance Wirkstoff (Principe actif)
No.13 kalium arsenicosum
26.0 MG Substance Wirkstoff (Principe actif)
No.21 zincum chloratum (zinci chloridum Ph.Eur.)
37.0 MG Substance Wirkstoff (Principe actif)
No.22 calcium carbonicum
37.0 MG Substance Wirkstoff (Principe actif)
calcii behenas
- Substance HNIDK
solani amylum
- Substance HNIDK
lactosum monohydricum
250.0 MG Substance HBESI

Authorization holder

Adler Pharma Helvetia AG

6060 Sarnen

Authorization information

Swissmedic authorization number
68745
Drug name
Adler Juvebene, Tabletten
Galenic form
TAB
Authorization status
Z
Dispensing category
D
First authorization
23/02/2023
Authorization expiration date
22/02/2028
IT Number
20.01.4.
Domain
Human medicine
Field of application
Gemäss dem biochemischen Therapieprinzip nach Dr. Schüssler bei Glieder- und Knochenschmerzen während der Wachstumsphase im Kindes- und Jugendalter.

Package details

Description (FR)
ADLER Juvebene cpr bte 400 pce
Description (DE)
ADLER Juvebene Tabl Ds 400 Stk
Market launch
23/02/2023
Narcotic (BTM)
No

Other package sizes (1)

None
1000 TABL
GTIN: None
Not in V1
Buy us a coffee Explore the data